These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2808383)

  • 1. Sphingosine inhibits monocyte tissue factor-initiated coagulation by altering factor VII binding.
    Conkling PR; Patton KL; Hannun YA; Greenberg CS; Weinberg JB
    J Biol Chem; 1989 Nov; 264(31):18440-4. PubMed ID: 2808383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administration.
    Kjalke M; Oliver JA; Monroe DM; Hoffman M; Ezban M; Hedner U; Roberts HR
    Thromb Haemost; 1997 Oct; 78(4):1202-8. PubMed ID: 9364985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
    Hattori T; Khan MM; Colman RW; Edmunds LH
    J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protamine inhibits tissue factor-initiated extrinsic coagulation.
    Chu AJ; Wang ZG; Raicu M; Beydoun S; Ramos N
    Br J Haematol; 2001 Nov; 115(2):392-9. PubMed ID: 11703341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade by ruthenium red of tissue factor-initiated coagulation.
    Chu AJ; Wang ZG; Nwobi OI; Beydoun S
    Br J Pharmacol; 2001 Jul; 133(5):659-64. PubMed ID: 11429389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine-containing phospholipid vesicles support human factor VII autoactivation in the absence of tissue factor.
    Iino M; Kisiel W
    Thromb Res; 1996 Apr; 82(2):119-27. PubMed ID: 9163065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen J; Knechtelsdorfer M; Stohlawetz P; Graninger W; Eichler HG; Speiser W; Jilma B
    Circulation; 1999 Dec 21-28; 100(25):2485-90. PubMed ID: 10604885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IV. Anticoagulant activity of compound 48/80: inhibition of factor VII activation in leukemia THP-1 monocytes.
    Chu AJ; Wang ZG; Raphael UO
    J Cardiovasc Pharmacol; 2000 Nov; 36(5):649-55. PubMed ID: 11065226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation.
    Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Roberts HR
    Thromb Haemost; 1998 Oct; 80(4):578-84. PubMed ID: 9798973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor-dependent autoactivation of human blood coagulation factor VII.
    Yamamoto M; Nakagaki T; Kisiel W
    J Biol Chem; 1992 Sep; 267(27):19089-94. PubMed ID: 1527033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen.
    Pernerstorfer T; Stohlawetz P; Hollenstein U; Dzirlo L; Eichler HG; Kapiotis S; Jilma B; Speiser W
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2517-23. PubMed ID: 10521382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit.
    Day KC; Hoffman LC; Palmier MO; Kretzmer KK; Huang MD; Pyla EY; Spokas E; Broze GJ; Warren TG; Wun TC
    Blood; 1990 Oct; 76(8):1538-45. PubMed ID: 2207329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
    Welsch DJ; Novotny WF; Wun TC
    Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII/VIIa protease activity.
    Tsao BP; Fair DS; Curtiss LK; Edgington TS
    J Exp Med; 1984 Apr; 159(4):1042-57. PubMed ID: 6368733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of procoagulant activity in stimulated mononuclear blood cells and monocytes by cyclosporine.
    Carlesen E; Prydz H
    Transplantation; 1987 Apr; 43(4):543-8. PubMed ID: 3576672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
    Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
    J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of human factor VII and VIIa to monocytes.
    Broze GJ
    J Clin Invest; 1982 Sep; 70(3):526-35. PubMed ID: 6980899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
    Hoffman M; Monroe DM
    Dis Mon; 2003 Jan; 49(1):14-21. PubMed ID: 12525825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cells and the activation of factor VII.
    Rao LV; Rapaport SI
    Haemostasis; 1996; 26 Suppl 1():1-5. PubMed ID: 8904164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.